Alejandro Perez-Fidalgo
Overview
Explore the profile of Alejandro Perez-Fidalgo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sorli J, de la Camara E, Fernandez-Carrion R, Asensio E, Portoles O, Ortega-Azorin C, et al.
Nutrients
. 2025 Jan;
17(1.
PMID: 39796538
Background And Objectives: Depression often results in premature aging, which increases the risk of other chronic diseases, but very few studies have analyzed the association between epigenetic biomarkers of aging...
2.
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer
Perez-Fidalgo A, Schmalfeldt B, George A, Gourley C, Pignata S, Lorusso D, et al.
Int J Gynecol Cancer
. 2024 Oct;
PMID: 39448084
Objectives: Maintenance therapies, including poly (ADP-ribose) polymerase (PARP) inhibitors and/or bevacizumab, have substantially improved the prognosis of patients with advanced ovarian cancer. Owing to the variability in treatment strategies across...
3.
Leary A, Estevez-Garcia P, Sabatier R, Ray-Coquard I, Romeo M, Barretina-Ginesta P, et al.
BMC Cancer
. 2024 Jul;
24(1):911.
PMID: 39075404
No abstract available.
4.
Leary A, Estevez-Garcia P, Sabatier R, Ray-Coquard I, Romeo M, Barretina-Ginesta P, et al.
BMC Cancer
. 2024 Jul;
24(1):876.
PMID: 39039449
Background: Carboplatin and paclitaxel (CP) have been the standard of care for advanced/recurrent endometrial cancer (EC) for many years. However, this chemotherapy combination shows limited efficacy and recurrences often occur...
5.
Coltell O, Asensio E, Sorli J, Ortega-Azorin C, Fernandez-Carrion R, Pascual E, et al.
Antioxidants (Basel)
. 2023 Nov;
12(11).
PMID: 38001857
Biological aging is a relevant risk factor for chronic diseases, and several indicators for measuring this factor have been proposed, with telomere length (TL) among the most studied. Oxidative stress...
6.
Redondo A, Barretina P, Perez-Fidalgo A, Rubio M, Gonzalez-Martin A
J Gynecol Oncol
. 2023 Apr;
34(5):e57.
PMID: 37116953
Objective: Our aim was to reach a consensus on the management of the most controversial issues of advanced ovarian cancer. Methods: Nominal group and Delphi techniques were used. A steering...
7.
Fernandez-Carrion R, Sorli J, Asensio E, Pascual E, Portoles O, Alvarez-Sala A, et al.
Int J Environ Res Public Health
. 2023 Feb;
20(4).
PMID: 36834337
Biomarkers based on DNA methylation are relevant in the field of environmental health for precision health. Although tobacco smoking is one of the factors with a strong and consistent impact...
8.
Barragan R, Fernandez-Carrion R, Asensio-Marquez E, Ortega-Azorin C, Alvarez-Sala A, Perez-Fidalgo A, et al.
Nutrients
. 2023 Feb;
15(3).
PMID: 36771415
Circadian rhythms regulate the sleep-wake and feeding-fasting cycles. Sleep and feeding constitute a complex cycle that is determined by several factors. Despite the importance of sleep duration and mealtimes for...
9.
Montero P, Milara J, Perez-Leal M, Estornut C, Roger I, Perez-Fidalgo A, et al.
Int J Mol Sci
. 2022 Feb;
23(3).
PMID: 35163066
Paclitaxel is a microtubule-stabilizing chemotherapeutic agent approved for the treatment of ovarian, non-small cell lung, head, neck, and breast cancers. Despite its beneficial effects on cancer and widespread use, paclitaxel...
10.
Gambardella V, Lombardi P, Carbonell-Asins J, Tarazona N, Cejalvo J, Gonzalez-Barrallo I, et al.
Br J Cancer
. 2021 Sep;
125(9):1261-1269.
PMID: 34493820
Introduction: Molecular-matched therapies have revolutionized cancer treatment. We evaluated the improvement in clinical outcomes of applying an in-house customized Next Generation Sequencing panel in a single institution. Methods: Patients with...